Penn Medicine has become the latest US based healthcare provider to open its doors in London.

The organisation, which is owned by the University of Pennsylvania, and operates a number of large hospitals and outpatient clinics across Philadelphia, has launched Penn Medicine London, which will offer referrals and telemedicine to patients from its base in Mayfair.

In 2017, Penn operated 2,876 beds and reported annual revenue of $7.8bn. Alongside its hospital business, it is a world-leading academic and medical research centre. It runs the oldest medical school in the US, Perelman School of Medicine, and is a global pioneer in new approaches to cancer treatment, in particular personalised cellular and proton beam therapies. Its chimeric antigen receptor T cell (CAR T) therapy, has recently been approved by the European Commission (EC) for two aggressive forms of cancer, including acute lymphoblastic leukaemia.

The new London centre is its first venture of this kind outside the US and will give patients from the UK and Europe access to its specialists and therapies.

Larry Jameson, MD, PhD, executive vice president of the University of Pennsylvania for the Health System and dean of Penn’s Perelman School of Medicine, said: ‘Penn Medicine London will provide enhanced access for patients seeking care from teams who are continuing to pioneer the next generation of prevention and treatment strategies for diseases of all kinds. The initiative also provides opportunities for innovative collaborations between Penn and UK and EU medical schools, including research-focused projects as well as physician exchange programs, ensuring the world’s brightest medical minds continue to share ideas and learn from each other.’

Despite political uncertainty, London remains an attractive destination for US healthcare operators. The Cleveland Clinic is due to open its new hospital in Grosvenor Place early in 2021 and the Mayo Clinic, in partnership with Oxford University, plans to open a screening and diagnostics centre in London early in 2019.

CEO of the University of Pennsylvania Health System Ralph Muller said: ‘Penn Medicine has a long history – dating past the founding of our nation – as a global health care leader, and we are pleased to extend our reach with a physical presence in the UK. We have always been proud of our role in training the world, and this initiative advances that mission by opening new doors and forging new relationships both in the UK and across Europe.’